Caring for yourself

As much as you care for your patients, it's important to step back occasionally and make sure you're not overlooking your own health. Nursing journals cite studies that show how oncology nurses are at higher risk for burnout,1 especially with the growing intensity of treatment protocols, staffing shortages, reduced hospital stays, and continuing pressure on the healthcare system.2

When surveyed, oncology nurses describe sources of job satisfaction in terms of patients, coworkers, and new skills. Ironically, these are also the primary source of job stress, along with issues around administrators, lack of time, and life stresses.3

It is generally agreed that nurses can benefit from programs that help develop coping skills, reduce stress, and build supportive relationships in the workplace. That's why it's important for nursing leadership to recognize the need for programs to address stress that can lead to burnout. At the same time, you owe it to yourself and your colleagues to bring stress issues to the attention of those in a position to help you.

Professional nursing organizations such as the Oncology Nursing Society (ONS) and the American Association of Critical Care Nurses (AACN) are good resources for information about how to stay healthy and avoid nursing burnout.

When you take care of yourself, you are in a better position to take care of others, too.

References

1. Barnardi M, Catania G, Marceca F. The world of nursing burnout. A literature review.
Prof Inferm. 2005;58:75-79.

2. Sherman AC, Edwards D, Simonton S, Mehta P. Caregiver stress and burnout in an oncology unit. Palliat Support Care. 2006;4:65-80.

3. Cohen MZ, Haberman MR, Steeves R, Deatrick JA. Rewards and difficulties of oncology nursing. Oncol Nurs Forum. 1994;21:9-17.


ALOXI (palonosetron HCl) injection 0.25 mg is indicated for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of moderately emetogenic chemotherapy, and acute nausea and vomiting associated with initial and repeat courses of highly emetogenic chemotherapy.

ALOXI is contraindicated in patients known to have hypersensitivity to the drug or any of its components. It should be administered with caution in patients who have or may develop prolongation of cardiac conduction intervals, particularly QTc. Most commonly reported adverse reactions include headache (9%) and constipation (5%).

ALOXI is available by prescription only. Please see the important product information for ALOXI for more information.

This site does not contain everything that is known about ALOXI. If you would like to know more, talk to your healthcare professional.